Insider Transactions in Q1 2023 at Vericel Corp (VCEL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.94%
|
$30,000
$10.6 P/Share
|
|
Feb 19
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-10.05%
|
$54,172
$29.82 P/Share
|
|
Feb 19
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+17.07%
|
-
|
|
Feb 19
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
752
-1.41%
|
$21,808
$29.82 P/Share
|
|
Feb 19
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+3.19%
|
-
|
|
Feb 19
2023
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-11.87%
|
$24,128
$29.82 P/Share
|
|
Feb 19
2023
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+19.98%
|
-
|
|
Feb 19
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,938
+4.73%
|
-
|
|
Feb 19
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,143
-2.3%
|
$120,147
$29.82 P/Share
|
|
Feb 18
2023
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-14.81%
|
$4,698
$29.82 P/Share
|
|
Feb 18
2023
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
419
+27.69%
|
-
|
|
Feb 18
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-8.28%
|
$38,628
$29.82 P/Share
|
|
Feb 18
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+14.88%
|
-
|
|
Feb 18
2023
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-7.21%
|
$30,885
$29.82 P/Share
|
|
Feb 18
2023
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,754
+15.72%
|
-
|
|
Feb 18
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-2.11%
|
$32,132
$29.82 P/Share
|
|
Feb 18
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,325
+4.24%
|
-
|
|
Feb 18
2023
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,155
-18.01%
|
$33,495
$29.82 P/Share
|
|
Feb 18
2023
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,325
+26.61%
|
-
|
|
Feb 18
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+6.22%
|
-
|
|
Feb 18
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,423
-3.07%
|
$157,267
$29.82 P/Share
|
|
Feb 11
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-12.99%
|
$57,507
$29.3 P/Share
|
|
Feb 11
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+18.65%
|
-
|
|
Feb 11
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
840
-1.65%
|
$24,360
$29.3 P/Share
|
|
Feb 11
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+3.09%
|
-
|
|
Feb 11
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-2.09%
|
$101,935
$29.3 P/Share
|
|
Feb 11
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.27%
|
-
|
|
Feb 06
2023
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-0.62%
|
$9,300
$30.6 P/Share
|
|
Feb 06
2023
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+1.29%
|
-
|
|
Feb 06
2023
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,253
-1.98%
|
$97,590
$30.6 P/Share
|
|
Feb 06
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+4.06%
|
-
|
|
Feb 06
2023
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
988
-7.75%
|
$29,640
$30.6 P/Share
|
|
Feb 06
2023
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+12.82%
|
-
|
|
Feb 02
2023
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
330
-32.84%
|
$10,230
$31.0 P/Share
|
|
Jan 10
2023
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
39,938
-20.27%
|
$1,078,326
$27.13 P/Share
|
|
Jan 10
2023
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,938
+16.86%
|
$998,450
$25.8 P/Share
|